These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2418866)

  • 1. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
    Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
    Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of proliferative diabetic retinopathy in which scintillating particles appeared in the intravitreal cavity after laser photocoagulation.
    Kohmoto R; Kobayashi T; Sato T; Kimura D; Fukumoto M; Tajiri K; Kida T; Ikeda T
    BMC Ophthalmol; 2017 Dec; 17(1):254. PubMed ID: 29258460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ULTRAHIGH SPEED SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL AND CHORIOCAPILLARIS ALTERATIONS IN DIABETIC PATIENTS WITH AND WITHOUT RETINOPATHY.
    Choi W; Waheed NK; Moult EM; Adhi M; Lee B; De Carlo T; Jayaraman V; Baumal CR; Duker JS; Fujimoto JG
    Retina; 2017 Jan; 37(1):11-21. PubMed ID: 27557084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal blood flow is increased in type 1 diabetes mellitus patients with advanced stages of retinopathy.
    Nguyen HT; van Duinkerken E; Verbraak FD; Polak BC; Ringens PJ; Diamant M; Moll AC
    BMC Endocr Disord; 2016 May; 16(1):25. PubMed ID: 27230581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RETINAL VASCULAR PERFUSION DENSITY MAPPING USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN NORMALS AND DIABETIC RETINOPATHY PATIENTS.
    Agemy SA; Scripsema NK; Shah CM; Chui T; Garcia PM; Lee JG; Gentile RC; Hsiao YS; Zhou Q; Ko T; Rosen RB
    Retina; 2015 Nov; 35(11):2353-63. PubMed ID: 26465617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycythemia-Related Proliferative Ischemic Retinopathy Managed with Smoking Cessation: A Case Report.
    Sung SY; Chang YC; Wu HJ; Lai HC
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on: Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy.
    Elnahry AG; Yussuf WA
    Eye (Lond); 2022 Aug; 36(8):1705. PubMed ID: 34616003
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparing the Early Treatment Diabetic Retinopathy Study 7-Field System With Ultrawide-Field Imaging.
    Feman SS
    JAMA Ophthalmol; 2019 Jan; 137(1):73-74. PubMed ID: 30347010
    [No Abstract]   [Full Text] [Related]  

  • 9. Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge.
    Mohite AA; Perais JA; McCullough P; Lois N
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in cell therapies using stem cells/progenitors as a novel approach for neurovascular repair of the diabetic retina.
    Lechner J; Medina RJ; Lois N; Stitt AW
    Stem Cell Res Ther; 2022 Jul; 13(1):388. PubMed ID: 35907890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of the molecular and cellular pathology of diabetic retinopathy.
    Antonetti DA; Silva PS; Stitt AW
    Nat Rev Endocrinol; 2021 Apr; 17(4):195-206. PubMed ID: 33469209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological changes in intraretinal microvascular abnormalities after anti-VEGF therapy visualized on optical coherence tomography angiography.
    Sorour OA; Mehta N; Baumal CR; Ishibazawa A; Liu K; Konstantinou EK; Martin S; Braun P; Alibhai AY; Arya M; Witkin AJ; Duker JS; Waheed NK
    Eye Vis (Lond); 2020; 7():29. PubMed ID: 32514410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflow of obstructed capillaries in the maculae of humans with diabetic retinopathy, observed by fluorescein angiography.
    Yamana Y; Oka Y; Ohnishi Y; Ishibashi T; Inoguchi T
    Br J Ophthalmol; 1988 Sep; 72(9):660-5. PubMed ID: 3179253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal revascularisation in diabetic retinopathy.
    Mohan R; Kohner EM
    Br J Ophthalmol; 1986 Feb; 70(2):114-7. PubMed ID: 2418866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial fenestrae in proliferative diabetic retinopathy.
    Wallow IH; Geldner PS
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1176-83. PubMed ID: 6158494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Panretinal photocoagulation and proliferative diabetic retinopathy. Results of a long-term prospective study (2d report)].
    Chaine G; Zerah I; Coscas G
    Bull Soc Ophtalmol Fr; 1986 Nov; 86(11):1369-72. PubMed ID: 2438060
    [No Abstract]   [Full Text] [Related]  

  • 17. Subretinal neovascularization complicating laser photocoagulation of diabetic maculopathy.
    Lewen RM
    Ophthalmic Surg; 1988 Oct; 19(10):734-7. PubMed ID: 2461540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.
    Wolbarsht ML; Landers MB
    Ophthalmic Surg; 1980 Apr; 11(4):235-45. PubMed ID: 6155650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant diabetic retinopathy].
    Shimizu K
    Nippon Ganka Gakkai Zasshi; 1988 Nov; 92(11):1723-39. PubMed ID: 2465678
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.